Do antibiotics improve neonatal outcomes in preterm premature rupture of membranes (PPROM)?
Grier
M
M
Lafayette Family Medicine Residency, New York, USA.
Weston
J
J
Xu
Y
Y
Patil
A
A
Epling
J
J
D019980:Amoxicillin-Potassium Clavulanate Combination / Q000627:therapeutic use*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004311:Double-Blind Method; D004359:Drug Therapy, Combination / Q000627:therapeutic use*; D004917:Erythromycin / Q000627:therapeutic use*; D005260:Female; D005322:Premature Rupture of Fetal Membranes / Q000188:drug therapy*; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000517:prevention & control*; D015337:Multicenter Studies as Topic; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic
D000900:Anti-Bacterial Agents; D004917:Erythromycin; D019980:Amoxicillin-Potassium Clavulanate Combination